Anixa Biosciences (ANIX) Payables (2010 - 2026)
Anixa Biosciences (ANIX) posted Payables of $282,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 2.2% from $276,000 a year earlier and up 11.9% from the prior quarter.
Powered by 
Analysis
Anixa Biosciences (ANIX) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), Anixa Biosciences' Payables came in at $165,000, down 68.6% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of -6.6% (FY2020 to FY2025).
- In prior fiscal years, Anixa Biosciences' Payables was $525,000 in FY2024 (+154.9%), $206,000 in FY2023 (-22.3%), $265,000 in FY2022 (+94.9%) and $136,000 in FY2021 (-41.5%).
- The fiscal Q3 2026 figure stands as the highest quarterly Payables since fiscal Q2 2025.
- On a year-over-year basis, Payables increased in four of the last seven quarters, with growth averaging 23.6%.
- The strongest year-over-year quarter for Payables in the past five years was fiscal Q1 2024, with growth of 230.9%; the weakest was fiscal Q2 2022, with a decline of 78.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Anixa Biosciences | 96.15 Mn | 81.01 Mn | - | 282,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 282,000.00 |
| Apr 30, 2026 | 252,000.00 |
| Oct 31, 2025 | 165,000.00 |
| Jul 31, 2025 | 276,000.00 |
| Apr 30, 2025 | 284,000.00 |
| Jan 31, 2025 | 600,000.00 |
| Oct 31, 2024 | 525,000.00 |
| Jul 31, 2024 | 302,000.00 |
| Apr 30, 2024 | 215,000.00 |
| Jan 31, 2024 | 364,000.00 |
| Oct 31, 2023 | 206,000.00 |
| Jul 31, 2023 | 94,000.00 |
| Apr 30, 2023 | 195,000.00 |
| Jan 31, 2023 | 110,000.00 |
| Oct 31, 2022 | 265,000.00 |
| Jul 31, 2022 | 227,000.00 |
| Apr 30, 2022 | 93,000.00 |
| Jan 31, 2022 | 504,000.00 |
| Oct 31, 2021 | 136,000.00 |
| Jul 31, 2021 | 207,733.00 |
API Access
Anixa Biosciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();